Contract Service Directory

Alliance Contract Pharma





Company Headquarters

1510 Delp Drive
Harleysville, PA 19438
United States

Company Description

Alliance Contract Pharma is a contract development and manufacturing organization (CDMO) providing contract analytical and manufacturing services to the pharmaceutical industry. Our FDA and DEA registered GMP facility allows us to formulate, develop and scale your drug product from pre-clinical through commercial manufacturing. Our manufacturing capabilities include expertise in the development and manufacturing of most solid, semi-solid, cream, liquid and suspension dosage forms. We are equipped to handle two unique manufacturing processes for the formulation and development of poorly soluble drugs including liquid filled capsules and wet milling. In addition, our ISO7/ISO 8 manufacturing area allows for the development and manufacturing of high potent compounds including injectable vial filling (post-sterilized). Our Analytical support our manufacturing capabilities and include method development, product release and ICH stability testing. Our unwavering commitment is to offer to you an environment and work ethic built upon core quality values of the highest degree, enabling you to successfully formulate, develop and scale your drug product in a timely manner. At all times we will work with you. Our goal is to continually advance the development and success of your drug product at every stage of development and at each milestone in the drug development process. No exceptions!

Contract Service Directory

    Related Content

    • Contracting And Outsourcing Exhibitor List

      2019 Exhibitors Company Table 3C PACKAGING 138 Adare Pharmaceuticals 97 Adents 123 Admix Pharma Labs 135 Advanced Analytical…
      09.17.19

    • Bio News | Biosimilars
      Know the Challenges of Biosimilar Manufacturing

      Know the Challenges of Biosimilar Manufacturing

      Best Practices for a Competitive Market
      Jerry Martin, Pharmaceutical and Life Sciences Consultant to PMMI, and, Dr. Michiel Ultee, Principal, Ulteemit BioConsulting, LLC 04.11.18

    • cGMP Manufacture | Information Technology
      Flexible Manufacturing Strategies and Data Integrity

      Flexible Manufacturing Strategies and Data Integrity

      Making processes integral with your data handling ability
      Emil W. Ciurczak, DoraMaxx Consulting 11.07.17


    • Breaking News | Clinical Trial Materials | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
      Capsugel Expands Capabilities

      Capsugel Expands Capabilities

      To offer more clinical trial services as well as high potency compounds
      11.01.17

    • APIs | Drug Development
      Frankfurt Hosts CPhI Worldwide 2017

      Frankfurt Hosts CPhI Worldwide 2017

      ICSE expo features 300 pharmaceutical outsourcing service providers, business development forum, networking, and sessions
      10.13.17

    • Aseptic Processing | Injectables
      Sterile Manufacturing: Future Trends and Challenges

      Sterile Manufacturing: Future Trends and Challenges

      By the middle of this century, biopharmaceuticals are set to overtake all other pharma sales
      Igor Gorsky, Concordia Valsource 10.11.17


    • cGMP Manufacture | Drug Development | Regulatory Affairs
      Contracting & Outsourcing Session Highlights and Key Takeaways

      Contracting & Outsourcing Session Highlights and Key Takeaways

      Insight into CMO Trends, Biotrends, Manufacturing Compliance, FDA Quality Agreements, and CMO Oversight
      Kristin Brooks, Contract Pharma 10.09.17

    • Analytical Services | Bioanalytical Services | cGMP Manufacture | Drug Development | Fill/Finish | Industry News
      Catalent to Acquire Cook Pharmica for $950M

      Catalent to Acquire Cook Pharmica for $950M

      Expands biologics development and analytical services, manufacturing, and finished product supply
      09.19.17

    • Biosimilars
      Know the Challenges of  Biosimilar Manufacturing

      Know the Challenges of Biosimilar Manufacturing

      Best practices for a competitive market
      Jerry Martin and Michiel Ultee 09.06.17


    • Promotions & Moves

      Akari Therapeutics Names New CEO

      Solomon to lead discovery platform and its clinical programs in PNH and aHUS
      08.21.17

    • Industry News | Laboratory Testing
      SGS Expands Capacity at Lincolnshire Facility

      SGS Expands Capacity at Lincolnshire Facility

      Doubles the site’s current footprint for a range of services
      08.08.17

    • Breaking News | cGMP Manufacture | Drug Development | Industry News | Regulatory Affairs
      Senate Passes FDA Reauthorization Act

      Senate Passes FDA Reauthorization Act

      Aims to allow faster approval of generic drugs and modifies fee structure for various stakeholders
      08.04.17


    • Clinical Trials | Collaborations & Alliances | Drug Development
      PDS, Merck Enter Keytruda Clinical Combo Alliance

      PDS, Merck Enter Keytruda Clinical Combo Alliance

      Will evaluate PDS' Versamune-based immunotherapy with Merck's Keytruda in head and neck cancer and HPV16 infection
      07.10.17

    • Collaborations & Alliances | Drug Development | Toxicology
      CytomX Achieves $15M AbbVie Milestone

      CytomX Achieves $15M AbbVie Milestone

      Advances CD71-Targeting Probody Drug Conjugate into GLP toxicology studies  
      06.29.17

    • Industry News | Serialization
      Adents Implements Multi-Site, Multi-line Serialization Solution

      Adents Implements Multi-Site, Multi-line Serialization Solution

      Installs serialization solution on packaging lines at four sites in France
      06.08.17

    • Inspections | Regulatory Affairs

      Warning Letters & Close-out Letters

      Why does it take so long to get a close-out letter?
      06.06.17

    • Breaking News | Industry News | Inspections
      BioPharma Services Completes 3 FDA Inspections

      BioPharma Services Completes 3 FDA Inspections

      No Form 483’s reported
      06.05.17

    • Collaborations & Alliances | Drug Development
      Array, BMS in Opdivo Clinical Combo Alliance

      Array, BMS in Opdivo Clinical Combo Alliance

      To investigate Array's binimetinib in combination with BMS' Opdivo and Opdivo + Yervoy regimen in colorectal cancer
      05.30.17

    • Breaking News | Facilities | Industry News | Inspections
      Frontida BioPharm Launches Expansion Efforts

      Frontida BioPharm Launches Expansion Efforts

      Comes on heels of receiving FDA clearance
      05.26.17

    • Regulatory Affairs
      The FDA and Metrics

      The FDA and Metrics

      The Agency and industry continue to work together to achieve FDA’s objectives
      David Lonza, Lachman Consultant Services, Inc. 05.09.17